Learn About Multicentric Reticulohistiocytosis

What is the definition of Multicentric Reticulohistiocytosis?
Multicentric reticulohistiocytosis is a disease that is characterized by the presence of papules and nodules and associated with arthritis mutilans. The disease can involve the skin, the bones, the tendons, the muscles, the joints, and nearly any other organ (e.g., eyes, larynx, thyroid, salivary glands, bone marrow, heart, lung, kidney, liver, gastrointestinal tract). In the majority of cases, the cause of Multicentric reticulohistiocytosis is unknown; however, it has been associated with an underlying cancer in about one fourth of cases, suggesting that it may be a paraneoplastic syndrome.
Save information for later
Sign Up
What are the alternative names for Multicentric Reticulohistiocytosis?
  • Multicentric reticulohistiocytosis
Who are the top Multicentric Reticulohistiocytosis Local Doctors?
ED
Dr. Eli L. Diamond
Neurology
Distinguished
Highly rated in
22
conditions
Neurology

Memorial Sloan Kettering Cancer Center

430 E 67th St 
New York, NY 10065

Eli Diamond is a Neurologist in New York, New York. Dr. Diamond has been practicing medicine for over 15 years and is rated as a Distinguished doctor by MediFind in the treatment of Multicentric Reticulohistiocytosis. He is also highly rated in 22 other conditions, according to our data. His top areas of expertise are Erdheim-Chester Disease, Brain Tumor, Glioma, and Glioblastoma. He is licensed to treat patients in New York. Dr. Diamond is currently accepting new patients.

View Profile
MH
Masatoshi Hotta
Distinguished
Highly rated in
4
conditions

National Center For Global Health And Medicine

Tokyo, JP 

Masatoshi Hotta is in Tokyo, Japan. Hotta is rated as a Distinguished expert by MediFind in the treatment of Multicentric Reticulohistiocytosis. He is also highly rated in 4 other conditions, according to our data. His top areas of expertise are Multicentric Reticulohistiocytosis, Pseudomyxoma Peritonei, Esophageal Cancer, and Sarcoidosis.

View Profile
 
 
 
 
Learn about our expert tiers
Learn more
AA
Achille Aouba
Distinguished
Highly rated in
39
conditions

Département De Médecine Interne

Caen, FR 

Achille Aouba is in Caen, France. Aouba is rated as a Distinguished expert by MediFind in the treatment of Multicentric Reticulohistiocytosis. He is also highly rated in 39 other conditions, according to our data. His top areas of expertise are Vasculitis, Temporal Arteritis, Giant Cell Arteritis GCA, and Juvenile Temporal Arteritis.

View Profile
View All Doctors
What are the latest Multicentric Reticulohistiocytosis Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Multicentric Reticulohistiocytosis?
Case Report: Multicentric Reticulohistiocytosis Associated With Posterior Mediastinal Adenosquamous Carcinoma, Antinuclear Antibody Positivity and Lupus Anticoagulant Positivity.
Journal: Frontiers in immunology
Published: January 24, 2022
View publication
Summary: Case Report: Multicentric Reticulohistiocytosis Associated With Posterior Mediastinal Adenosquamous Carcinoma, Antinuclear Antibody Positivity and Lupus Anticoagulant Positivity.
Multicentric reticulohistiocytosis: A case report.
Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Published: December 17, 2021
View publication
Summary: Multicentric reticulohistiocytosis: A case report.
Tired of the same old research?
Check Latest Advances
Multicentric Reticulohistiocytosis: Elective Excision of Symptomatic Hand Nodules With 1-Year Follow-Up.
Condition: Multicentric Reticulohistiocytosis
Journal: The Journal of hand surgery
Treatment Used: Excision of Hand Nodules
Number of Patients: 300
Published: July 20, 2019
View publication
Summary: Multicentric Reticulohistiocytosis: Elective Excision of Symptomatic Hand Nodules With 1-Year Follow-Up.
View All Latest Advances